Jason R. Kelly
Chief Executive Officer & Founder, Director · Ginkgo Bioworks Holdings, Inc.
- 2026
- Jul 30, 2026
- 2
Summary
Latest filing:
Jason R. Kelly is Chief Executive Officer & Founder, Director of Ginkgo Bioworks Holdings, Inc. (DNA). 2 SEC Form 4 filings on record, most recently on 30 July 2026. Most recent open-market trade: sold $702K of DNA on 10 April 2026. Lifetime open-market sales: $1.37M.
Recent transactions
4The latest 4 SEC Form 4 transactions reported by Jason R. Kelly.
Trading pattern
InsiderAlpha's records for Jason R. Kelly go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jason R. Kelly files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Reshma P. Shetty - $978K in DNA purchases and sales in the last 12 months
- Barry Canton - $978K in DNA purchases and sales in the last 12 months
- Steven P. Coen - $300K in DNA purchases and sales in the last 12 months
- Christian O. Henry - $35K in DNA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jason R. Kelly?
Jason R. Kelly is a corporate insider, tracked as Chief Executive Officer & Founder, Director of Ginkgo Bioworks Holdings, Inc. (DNA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jason R. Kelly submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jason R. Kelly been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($1.37M) across all tracked filings.